EssilorLuxottica had one patents in cybersecurity during Q4 2023. EssilorLuxottica SA has developed a system that analyzes the efficacy of myopia control solutions over time to determine the best moment for modifying or changing the initial solution used by a myopic individual. This system compares the efficacy of the initial solution with other available solutions in a database, and recommends a change if a more effective solution is identified at a later time. GlobalData’s report on EssilorLuxottica gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
EssilorLuxottica grant share with cybersecurity as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: System and method for determining an appropriate moment for modifying or changing an initial myopia control solution (Patent ID: US20230411021A1)
The patent filed by EssilorLuxottica SA describes a system for determining the appropriate time to modify or change an initial myopia control solution used by a myopic individual. The system utilizes a database of available myopia control solutions and data on the efficacy of each solution over time. By evaluating specific criteria at different time points, the system can compare the efficacy of the initial solution with other options in the database and recommend a change if necessary. The criteria considered include factors like time spent using the solution and the subject's activity level. Additionally, the system can monitor the subject and their environment, taking into account individual features to tailor the myopia control solution effectively.
Furthermore, the system can preselect a group of myopia control solutions based on individual features of the subject, update these features over time, and determine the most suitable solution accordingly. The system also considers various features of the subject, such as historical, optometric, biometric, health, visual behavior, and postural aspects, to provide personalized recommendations. By incorporating a range of actions like correcting accommodative lag, providing retinal stimulation, and reshaping the cornea, the system offers a comprehensive approach to myopia control. Overall, the patent outlines a sophisticated system that leverages data and individual characteristics to optimize myopia control solutions for better efficacy and outcomes.
To know more about GlobalData’s detailed insights on EssilorLuxottica, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
